Health

For Diabetics, a New Insulin Inhaler Could Replace Shots as Early as 2014

[Business Week] The long promise of insulin that diabetics can inhale appears to be moving closer to the market. An inhalable insulin powder called Afrezza showed positive results for controlling diabetes in a late-stage clinical trial, the drug’s maker, MannKind (MNKD), reported today. Pharmaceutical companies have been Read More